ProSpective MultIcenter ObservationaL Study on the Quality of Life of mCRC RAS Wild-type Patients Receiving Anti-EGFR MAbs + FOLFOX or FOLFIRI as 1st Line of Treatment (20140383)

11/02/2022
02/04/2024
EU PAS number:
EUPAS44300
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Protocol-Published Original panitumumab 20140383

English (742.96 KB - PDF) View document
Study results
Study results

20140383_CSR _Synopsis_Redacted

English (197.78 KB - PDF) View document
Study report
Other information